These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease. Matsunaga M, Eguchi K, Fukuda T, Kurata A, Tezuka H, Shimomura C, Otsubo T, Ishikawa N, Ito K, Nagataki S. J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570 [Abstract] [Full Text] [Related]
3. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease. Iwatani Y, Gerstein HC, Iitaka M, Row VV, Volpé R. J Clin Endocrinol Metab; 1986 Sep; 63(3):695-708. PubMed ID: 3090094 [Abstract] [Full Text] [Related]
4. Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease. Eguchi K, Otsubo T, Kawabe Y, Shimomura C, Ueki Y, Nakao H, Tezuka H, Matsunaga M, Fukuda T, Ishikawa N. Clin Exp Immunol; 1988 Apr; 72(1):84-90. PubMed ID: 3260842 [Abstract] [Full Text] [Related]
5. Lack of B7-1/BB1 and B7-2/B70 expression on thyrocytes of patients with Graves' disease. Delivery of costimulatory signals from bystander professional antigen-presenting cells. Matsuoka N, Eguchi K, Kawakami A, Tsuboi M, Nakamura H, Kimura H, Ishikawa N, Ito K, Nagataki S. J Clin Endocrinol Metab; 1996 Nov; 81(11):4137-43. PubMed ID: 8923872 [Abstract] [Full Text] [Related]
6. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production. Iwatani Y, Iitaka M, Row VV, Volpé R. Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474 [Abstract] [Full Text] [Related]
7. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression. Aguayo J, Iitaka M, Row VV, Volpé R. J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449 [Abstract] [Full Text] [Related]
8. The in vitro regulation of human thyrocyte HLA-DR antigen expression. Weetman AP, Volkman DJ, Burman KD, Gerrard TL, Fauci AS. J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430 [Abstract] [Full Text] [Related]
9. Separate induction of MHC and thyroid microsomal antigen (McAg) expression on thyroid cell monolayers: enhancement of lectin-induced McAg expression by interferon-gamma. Iwatani Y, Iitaka M, Gerstein HC, Row VV, Volpé R. J Clin Endocrinol Metab; 1987 Jun; 64(6):1302-8. PubMed ID: 3106398 [Abstract] [Full Text] [Related]
10. Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-gamma. Margolick JB, Weetman AP, Burman KD. Clin Immunol Immunopathol; 1988 May; 47(2):208-18. PubMed ID: 2964967 [Abstract] [Full Text] [Related]
11. Function of DR-positive thyrocytes from patients with Graves' disease: quantitative analysis of thyroid peroxidase content by fluorescent photometry. Asakawa H, Hanafusa T, Kuma K, Kono N, Tarui S. J Clin Endocrinol Metab; 1992 Mar; 74(3):614-8. PubMed ID: 1740495 [Abstract] [Full Text] [Related]
12. [Effects of prolactin on in-vitro interactions between thyrocytes from patients with Graves' disease and autologous peripheral blood mononuclear cells]. Li J, Shan Z, Teng W. Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):82-5. PubMed ID: 11798558 [Abstract] [Full Text] [Related]
13. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Kawai K, Enomoto T, Fornasier V, Resetkova E, Volpé R. Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581 [Abstract] [Full Text] [Related]
14. HLA-DR antigen expression on intrathyroidal lymphocytes and thyrocytes in Hashimoto's thyroiditis and Graves' disease: an immunohistological study. Misaki T, Konishi J, Arai K, Iida Y, Kasagi K, Kuma K, Torizuka K. Endocrinol Jpn; 1987 Apr; 34(2):257-62. PubMed ID: 3113922 [Abstract] [Full Text] [Related]
15. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect? Sospedra M, Obiols G, Babi LF, Tolosa E, Vargas F, Roura-Mir C, Lucas-Martin A, Ercilla G, Pujol-Borrell R. J Immunol; 1995 Apr 15; 154(8):4213-22. PubMed ID: 7706756 [Abstract] [Full Text] [Related]
16. The interaction of MHC and Gm in liability to autoimmune thyroid disease. Nagataki S. Mol Biol Med; 1986 Feb 15; 3(1):73-84. PubMed ID: 3007922 [Abstract] [Full Text] [Related]
17. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG. Bodolay E, Szegedi G, Suranyi P, Juhasz F, Stenszky V, Balazs C, Farid NR. Immunol Lett; 1987 May 15; 15(1):77-81. PubMed ID: 3111991 [Abstract] [Full Text] [Related]
18. Effects of supernatants of peripheral blood mononuclear cells stimulated by thyroid microsomal antigen on thyrocyte HLA-dr expression in vitro. Matsubayashi S, Sakatsume Y, Kasuga Y, Tamai H, Volpé R. Autoimmunity; 1990 May 15; 8(2):91-6. PubMed ID: 2129496 [Abstract] [Full Text] [Related]
20. Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-gamma-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cells. Hiromatsu Y, Sato M, Yamada K, Nonaka K. Clin Endocrinol (Oxf); 1992 Jan 15; 36(1):91-5. PubMed ID: 1532770 [Abstract] [Full Text] [Related] Page: [Next] [New Search]